학술논문
Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy
Document Type
Article
Author
Source
In: Therapeutic Advances in Respiratory Disease . (Therapeutic Advances in Respiratory Disease, 1 October 2016, 10(5):391-401)
Subject
Language
English
ISSN
17534666
17534658
17534658